Nutrition Assessment and Monitoring and Evaluation Terminology

This is a combined list of Nutrition Assessment and Monitoring and Evaluation terms. Indicators that are shaded are used ONLY for nutrition
assessment. The rest of the indicators are used for assessment and monitoring and evaluation. Each term has an Academy unique identifier, a five-digit
number (e.g., 99999) following the alpha-numeric IDNT code. Neither should be visible in nutrition documentation. The Academy unique identifier is
for data tracking purposes in electronic health records.
FOOD/NUTRITION-Related HISTORY (FH) Fat and cholesterol intake (1.5.1), cont’d
Food and nutrient intake, food and nutrient administration, medication and q Polyunsaturated fat FH-1.5.1.4 10047
complementary/alternative medicine use, knowledge/beliefs/attitudes, behavior, food q Monounsaturated fat FH-1.5.1.5 10048
and supply availability, physical activity and function, nutrition-related patient/ q Omega-3 fatty acids FH-1.5.1.6 10049
client-centered measures. q Dietary cholesterol FH-1.5.1.7 10050
q Essential fatty acids FH-1.5.1.8 10051
Food and Nutrient Intake (1)
Protein intake (1.5.2)
Composition and adequacy of food and nutrient intake, meal and snack patterns,
q Total protein FH-1.5.2.1 10053
current and previous diets and/or food modifications, and eating environment.
q High biological value protein FH-1.5.2.2 10054
Energy Intake (1.1) q Casein FH-1.5.2.3 10055
Total energy intake from all sources including food, beverages, breastmilk/formula, q Whey FH-1.5.2.4 10056
supplements, and via enteral and parenteral routes. q Amino acids FH-1.5.2.5 10057
Energy intake (1.1.1) q Essential amino acids FH-1.5.2.6 10058
q Total energy intake FH-1.1.1.1 10005 Carbohydrate intake (1.5.3)

Montioring & Evaluation

Food and Beverage Intake (1.2) q Total carbohydrate FH-1.5.3.1 10060
Type, amount, and pattern of intake of foods and food groups, indices of diet quality, q Sugar FH-1.5.3.2 10061
intake of fluids, breastmilk and infant formula q Starch FH-1.5.3.3 10062

Assessment &
q Glycemic index FH-1.5.3.4 10063
Fluid/beverage intake (1.2.1)
q Glycemic load FH-1.5.3.5 10064
q Oral fluids FH-1.2.1.1 10008
q Source of carbohydrate FH-1.5.3.6 10065
q Food-derived fluids FH-1.2.1.2 10009
q Insulin-to-carbohydrate ratio FH-1.5.3.7 10066
q Liquid meal replacement or supplement FH-1.2.1.3 10010
Fiber intake (1.5.4)
Food intake (1.2.2)
q Total fiber FH-1.5.4.1 10068
q Amount of food FH-1.2.2.1 10012
q Soluble fiber FH-1.5.4.2 10069
q Types of food/meals FH-1.2.2.2 10013
q Insoluble fiber FH-1.5.4.3 10070
q Meal/snack pattern FH-1.2.2.3 10014
q Diet quality index FH-1.2.2.4 10015 Micronutrient Intake (1.6)
q Food variety FH-1.2.2.5 10016 Vitamin and mineral intake from all sources, e.g., food, beverages, supplements, and
via enteral and parenteral routes.
Breastmilk/infant formula intake (1.2.3)
q Breastmilk intake FH-1.2.3.1 10018 Vitamin intake (1.6.1)
q Infant formula intake FH-1.2.3.2 10019 q A (1) 10073 q Niacin (8) 10080
q C (2) 10074 q Folate (9) 10081
Enteral and Parenteral Nutrition Intake (1.3)
q D (3) 10075 q B6 (10) 10082
Specialized nutrition support intake from all sources, e.g., enteral and parenteral
q E (4) 10076 q B12 (11) 10083
routes.
q K (5) 10077 q Pantothenic acid (12) 10084
Enteral nutrition intake (1.3.1) q Thiamin (6) 10078 q Biotin (13) 10085
q Formula/solution FH-1.3.1.1 10022 q Riboflavin (7) 10079 q Multivitamin (14) 10086
q Feeding tube flush FH-1.3.1.2 10023
Mineral/element intake (1.6.2)
Parenteral nutrition intake (1.3.2) q Calcium (1) 10089 q Copper (11) 10099
q Formula/solution FH-1.3.2.1 10025 q Chloride (2) 10090 q Iodine (12) 10100
q IV fluids FH-1.3.2.2 10026 q Iron (3) 10091 q Selenium (13) 10101
Bioactive Substance Intake (1.4) q Magnesium (4) 10092 q Manganese (14) 10102
Alcohol, plant stanol and sterol esters, soy protein, psyllium and b-glucan, and q Potassium (5) 10093 q Chromium (15) 10103
caffeine intake from all sources, e.g., food, beverages, supplements, and via enteral q Phosphorus (6) 10094 q Molybdenum (16) 10104
and parenteral routes. q Sodium (7) 10095 q Boron (17) 10105
q Zinc (8) 10096 q Cobalt (18) 10106
Alcohol intake (1.4.1)
q Sulfate (9) 10097 q Multi-mineral (19) 10107
q Drink size/volume FH-1.4.1.1 10029
q Fluoride (10) 10098 q Multi-trace element (20) 10108
q Frequency FH-1.4.1.2 10030
q Pattern of alcohol consumption FH-1.4.1.3 10031 Food and Nutrient Administration (2)
Bioactive substance intake (1.4.2) Current and previous diets and/or food modifications, eating environment, and
q Plant stanol esters FH-1.4.2.1 10034 enteral and parenteral nutrition administration.
q Plant sterol esters FH-1.4.2.2 10807 Diet History (2.1)
q Soy protein FH-1.4.2.3 10035 Description of food and drink regularly provided or consumed, past diets followed
q Psyllium FH-1.4.2.4 10827 or prescribed and counseling received, and the eating environment.
q b-glucan FH-1.4.2.5 10037
Diet order (2.1.1)
q Food additives (specify) FH-1.4.2.6 10038
q General, healthful diet FH-2.1.1.1 10113
q Other (specify) FH-1.4.2.7 10039
q Modified diet FH-2.1.1.2 10114
Caffeine intake (1.4.3) q Enteral nutrition order FH-2.1.1.3 10115
q Total caffeine FH-1.4.3.1 10041 q Parenteral nutrition order FH-2.1.1.4 10116
Macronutrient Intake (1.5) Diet experience (2.1.2)
Fat and cholesterol, protein, carbohydrate, and fiber intake from all sources q Previously prescribed diets FH-2.1.2.1 10118
including food, beverages, supplements, and via enteral and parenteral routes. q Previous diet/nutrition education/counseling FH-2.1.2.2 10119
Fat and cholesterol intake (1.5.1) q Self-selected diet/s followed FH-2.1.2.3 10120
q Total fat FH-1.5.1.1 10044 q Dieting attempts FH-2.1.2.4 10121
q Saturated fat FH-1.5.1.2 10045 q Food allergies FH-2.1.2.5 10805
q Trans fatty acids FH-1.5.1.3 10046 q Food intolerance FH-2.1.2.6 10806

415 4th Edition

 Nutrition Assessment and Monitoring and Evaluation Terminology, cont’d
Eating environment (2.1.3) Mealtime behavior (5.4), cont’d
q Location FH-2.1.3.1 10123 q Willingness to try new foods FH-5.4.8 10180
q Atmosphere FH-2.1.3.2 10124 q Limited number of accepted foods FH-5.4.9 10181
q Caregiver/companion FH-2.1.3.3 10125 q Rigid sensory preferences FH-5.4.10 10182
q Appropriate breastfeeding accommodations/facility FH-2.1.3.4 10126 Social network (5.5)
q Eats alone FH-2.1.3.5 10127 q Ability to build and utilize social network FH-5.5.1 10184
Enteral and parenteral nutrition administration (2.1.4)
q Enteral access FH-2.1.4.1 10129 Factors Affecting Access to Food and Food/Nutrition-Related
q Parenteral access FH-2.1.4.2 10130 Supplies (6)
q Body position, EN FH-2.1.4.3 10804 Factors that affect intake and availability of a sufficient quantity of safe, healthful
food as well as food/nutrition-related supplies.
Medication and Complementary/Alternative Medicine Use (3) Food/nutrition program participation (6.1)
Prescription and over-the-counter medications, including herbal preparations and
q Eligibility for government programs FH-6.1.1 10187
complementary/alternative medicine products used.
q Participation in government programs FH-6.1.2 10188
Medications (3.1) q Eligibility for community programs FH-6.1.3 10189
q Prescription medication use FH-3.1.1 10820 q Participation in community programs FH-6.1.4 10190
q OTC medication use FH-3.1.2 10134
Safe food/meal availability (6.2)
q Misuse of medication FH-3.1.3 10135
q Availability of shopping facilities FH-6.2.1 10192
Montioring & Evaluation

Complementary/Alternative Medicine (3.2) q Procurement of safe food FH-6.2.2 10800

q Nutrtion-related complementary/alternative FH-3.2.1 10137 q Appropriate meal preparation facilities FH-6.2.3 10194
medicine use q Availability of safe food storage FH-6.2.4 10195
Assessment &

q Appropriate storage technique FH-6.2.5 10196

Knowledge/Beliefs/Attitudes (4) q Identification of safe food FH-6.2.6 10801
Understanding of nutrition-related concepts and conviction of the truth and feelings/
emotions toward some nutrition-related statement or phenomenon, along with Safe water availability (6.3)
readiness to change nutrition-related behaviors. q Availability of potable water FH-6.3.1 10198
q Appropriate water decontamination FH-6.3.2 10199
Food and nutrition knowledge/skill (4.1)
q Area(s) and level of knowledge/skill FH-4.1.1 10848 Food and nutrition-related supplies availability (6.4)
q Diagnosis specific or global nutrition-related FH-4.1.2 10143 q Access to food and nutrition-related supplies FH-6.4.1 10201
knowledge score q Access to assistive eating devices FH-6.4.2 10202
q Access to assistive food preparation devices FH 6.4.3 10203
Beliefs and attitudes (4.2)
q Conflict with personal/family value system FH-4.2.1 10145 Physical Activity and Function (7)
q Distorted body image FH-4.2.2 10146 Physical activity, cognitive and physical ability to engage in specific tasks, e.g.,
q End-of-life decisions FH-4.2.3 10147 breastfeeding, self-feeding.
q Motivation FH-4.2.4 10148
Breastfeeding (7.1)
q Preoccupation with food/nutrients FH-4.2.5 10149
q Initiation of breastfeeding FH-7.1.1 10206
q Preoccupation with weight FH-4.2.6 10150
q Duration of breastfeeding FH-7.1.2 10207
q Readiness to change nutrition-related behaviors FH-4.2.7 10151
q Exclusive breastfeeding FH-7.1.3 10208
q Self-efficacy FH-4.2.8 10152
q Breastfeeding problems FH-7.1.4 10209
q Self-talk/cognitions FH-4.2.9 10153
q Unrealistic nutrition-related goals FH-4.2.10 10154 Nutrition-related ADLs and IADLs (7.2)
q Unscientific beliefs/attitudes FH-4.2.11 10155 q Physical ability to complete tasks for FH-7.2.1 10211
q Food preferences FH-4.2.12 10156 meal preparation
q Emotions FH-4.2.13 10157 q Physical ability to self-feed FH-7.2.2 10212
q Ability to position self in relation to plate FH-7.2.3 10213
Behavior (5) q Receives assistance with intake FH 7.2.4 10214
Patient/client activities and actions, which influence achievement of nutrition-related q Ability to use adaptive eating devices FH 7.2.5 10215
goals. q Cognitive ability to complete tasks for FH-7.2.6 10216
Adherence (5.1) meal preparation
q Self-reported adherence score FH-5.1.1 10160 q Remembers to eat FH-7.2.7 10139
q Nutrition visit attendance FH-5.1.2 10161 q Recalls eating FH-7.2.8 10218
q Ability to recall nutrition goals FH-5.1.3 10162 q Mini Mental State Examination Score FH-7.2.9 10219
q Self-monitoring at agreed upon rate FH-5.1.4 10163 q Nutrition-related activities of daily living FH-7.2.10 10220
q Self-management as agreed upon FH-5.1.5 10164 (ADL) score
q Nutrition-related instrumental activities of FH-7.2.11 10221
Avoidance behavior (5.2) daily living (IADL) score
q Avoidance FH-5.2.1 10166
q Restrictive eating FH-5.2.2 10167 Physical activity (7.3)
q Cause of avoidance behavior FH-5.2.3 10168 q Physical activity history FH-7.3.1 10223
q Consistency FH-7.3.2 10224
Bingeing and purging behavior (5.3) q Frequency FH-7.3.3 10225
q Binge eating behavior FH-5.3.1 10170 q Duration FH-7.3.4 10226
q Purging behavior FH-5.3.2 10171 q Intensity FH-7.3.5 10227
Mealtime behavior (5.4) q Type of physical activity FH-7.3.6 10228
q Meal duration FH-5.4.1 10173 q Strength FH-7.3.7 10229
q Percent of meal time spent eating FH-5.4.2 10174 q TV/screen time FH-7.3.8 10230
q Preference to drink rather than eat FH-5.4.3 10175 q Other sedentary activity time FH-7.3.9 10231
q Refusal to eat/chew FH-5.4.4 10176 q Involuntary physical movement FH-7.3.10 10232
q Spitting food out FH-5.4.5 10177 q NEAT FH-7.3.11 10233
q Rumination FH-5.4.6 10178
q Patient/client/caregiver fatigue during feeding FH-5.4.7 10179
process resulting in inadequate intake

4th Edition 416

 Nutrition Assessment and Monitoring and Evaluation Terminology, cont’d
Factors affecting access to physical activity (7.4) Gastrointestinal profile (1.4), cont’d
q Neighborhood safety FH-7.4.1 10822 q Gastric emptying time BD-1.4.20 10290
q Walkability of neighborhood FH-7.4.2 10823 q Small bowel transit time BD-1.4.21 10291
q Proximity to parks/green space FH-7.4.3 10824 q Abdominal films BD-1.4.22 10292
q Access to physical activity facilities/programs FH-7.4.4 10825 q Swallow study BD-1.4.23 10293
Glucose/endocrine profile (1.5)
Nutrition-Related Patient/Client-Centered Measures (8)
q Glucose, fasting BD-1.5.1 10295
Patient/client’s perception of his or her nutrition intervention and its impact on life.
q Glucose, casual BD-1.5.2 10296
Nutrition quality of life (8.1) q HgbA1c BD-1.5.3 10297
q Nutrition quality of life responses FH-8.1.1 10236 q Preprandial capillary plasma glucose BD-1.5.4 10298
q Peak postprandial capillary plasma glucose BD-1.5.5 10299
Anthropometric Measurements (AD)
q Glucose tolerance test BD-1.5.6 10300
Height, weight, body mass index (BMI), growth pattern indices/percentile ranks, and
q Cortisol level BD-1.5.7 10301
weight history.
q IGF-binding protein BD-1.5.8 10302
Body composition/growth/weight history (1.1) q Thyroid function tests (TSH, T4, T3) BD-1.5.9 10303
q Height/length AD-1.1.1 10239 q Pituitary hormone tests (GH, ACTH, LH, FSH) BD-1.5.10 10826
q Weight AD-1.1.2 10240
Inflammatory profile (1.6)
q Frame size AD-1.1.3 10241
q C-reactive protein BD-1.6.1 10305
q Weight change AD-1.1.4 10242

Montioring & Evaluation

q Body mass index AD-1.1.5 10243 Lipid profile (1.7)
q Growth pattern indices/percentile ranks AD-1.1.6 10244 q Cholesterol, serum BD-1.7.1 10307
q Body compartment estimates AD-1.1.7 10245 q Cholesterol, HDL BD-1.7.2 10308

Assessment &
q Cholesterol, LDL BD-1.7.3 10309
Biochemical Data, Medical Tests q Cholesterol, non-HDL BD-1.7.4 10310
and PROCEDURES (BD) q Total cholesterol:HDL cholesterol BD-1.7.5 10311
Laboratory data, (e.g., electrolytes, glucose, and lipid panel) and tests (e.g., gastric q LDL:HDL BD-1.7.6 10312
emptying time, resting metabolic rate). q Triglycerides, serum BD-1.7.7 10313
Acid-base balance (1.1) Metabolic rate profile (1.8)
q Arterial pH BD-1.1.1 10248 q Resting metabolic rate, measured BD-1.8.1 10315
q Arterial bicarbonate BD-1.1.2 10249 q Respiratory quotient, measured BD-1.8.2 10316
q Partial pressure of carbon dioxide in arterial BD-1.1.3 10250 Mineral profile (1.9)
blood, PaCO2 q Copper, serum or plasma BD-1.9.1 10318
q Partial pressure of oxygen in arterial blood, PaO2 BD-1.1.4 10251 q Iodine, urinary excretion BD-1.9.2 10319
q Venous pH BD-1.1.5 10252 q Zinc, serum or plasma BD-1.9.3 10320
q Venous bicarbonate BD-1.1.6 10253 q Boron, serum or plasma BD-1.9.4 10841
Electrolyte and renal profile (1.2) q Chromium, serum or urinary BD-1.9.5 10842
q BUN BD-1.2.1 10255 q Fluoride, plasma BD-1.9.6 10843
q Creatinine BD-1.2.2 10256 q Manganese, urinary, blood, plasma BD-1.9.7 10844
q BUN:creatinine ratio BD-1.2.3 10257 q Molybdenum, serum BD-1.9.8 10845
q Glomerular filtration rate BD-1.2.4 10258 q Selenium, serum or urinary BD-1.9.9 10846
q Sodium BD-1.2.5 10259 Nutritional anemia profile (1.10)
q Chloride BD-1.2.6 10260 q Hemoglobin BD-1.10.1 10323
q Potassium BD-1.2.7 10261 q Hematocrit BD-1.10.2 10324
q Magnesium BD-1.2.8 10262 q Mean corpuscular volume BD-1.10.3 10325
q Calcium, serum BD-1.2.9 10263 q Red blood cell folate BD-1.10.4 10326
q Calcium, ionized BD-1.2.10 10264 q Red cell distribution width BD-1.10.5 10327
q Phosphorus BD-1.2.11 10265 q B12, serum BD-1.10.6 10328
q Serum osmolality BD-1.2.12 10266 q Methylmalonic acid, serum BD-1.10.7 10329
q Parathyroid hormone BD-1.2.13 10267 q Folate, serum BD-1.10.8 10330
Essential fatty acid profile (1.3) q Homocysteine, serum BD-1.10.9 10331
q Triene:Tetraene ratio BD-1.3.1 10269 q Ferritin, serum BD-1.10.10 10332
Gastrointestinal profile (1.4) q Iron, serum BD-1.10.11 10333
q Alkaline phosphatase BD-1.4.1 10271 q Total iron-binding capacity BD-1.10.12 10334
q Alanine aminotransferase, ALT BD-1.4.2 10272 q Transferrin saturation BD-1.10.13 10335
q Aspartate aminotransferase, AST BD-1.4.3 10273 Protein profile (1.11)
q Gamma glutamyl transferase, GGT BD-1.4.4 10274 q Albumin BD-1.11.1 10337
q Gastric residual volume BD-1.4.5 10275 q Prealbumin BD-1.11.2 10338
q Bilirubin, total BD-1.4.6 10276 q Transferrin BD-1.11.3 10339
q Ammonia, serum BD-1.4.7 10277 q Phenylalanine, plasma BD-1.11.4 10340
q Toxicology report, including alcohol BD-1.4.8 10278 q Tyrosine, plasma BD-1.11.5 10341
q Prothrombin time, PT BD-1.4.9 10279 q Amino acid, other, specify BD-1.11.6 10342
q Partial thromboplastin time, PTT BD-1.4.10 10280 q Antibody level, specify BD-1.11.7 10343
q INR (ratio) BD-1.4.11 10281 q Carbohydrate-deficient transferrin BD-1.11.8 10847
q Fecal fat BD-1.4.12 10282 Urine profile (1.12)
q Amylase BD-1.4.13 10283 q Urine color BD-1.12.1 10345
q Lipase BD-1.4.14 10284 q Urine osmolality BD-1.12.2 10346
q Other digestive enzymes (specify) BD-1.4.15 10285 q Urine specific gravity BD-1.12.3 10347
q D-xylose BD-1.4.16 10286 q Urine test, specify BD-1.12.4 10348
q Hydrogen breath test BD-1.4.17 10287 q Urine volume BD-1.12.5 10349
q Intestinal biopsy BD-1.4.18 10288
q Stool culture BD-1.4.19 10289

417 4th Edition

 Nutrition Assessment and Monitoring and Evaluation Terminology, cont’d
Vitamin profile (1.13) Patient/client OR family nutrition-oriented medical/health history (2.1), cont’d
q Vitamin A, serum or plasma retinol BD-1.13.1 10351 Specify issue(s) and whether it is patient/client history (P) or family history (F)
q Vitamin C, plasma or serum BD-1.13.2 10352 q Gastrointestinal CH-2.1.5 10390
q Vitamin D, 25-hydroxy BD-1.13.3 10353 (specify) ___________________________________ P or F
q Vitamin E, plasma alpha-tocopherol BD-1.13.4 10354 q Gynecological CH-2.1.6 10391
q Thiamin, activity coefficient for erythrocyte BD-1.13.5 10355 (specify) ___________________________________ P or F
transketolase activity q Hematology/oncology CH-2.1.7 10392
q Riboflavin, activity coefficient for erythrocyte BD-1.13.6 10356 (specify) ___________________________________ P or F
glutathione reductase activity q Immune (e.g., food allergies) CH-2.1.8 10393
q Niacin, urinary N’methyl-nicotinamide BD-1.13.7 10357 (specify) ___________________________________ P or F
concentration q Integumentary CH-2.1.9 10394
q Vitamin B6, plasma or serum pyridoxal BD-1.13.8 10358 (specify) ___________________________________ P or F
5’phosphate concentration q Musculoskeletal CH-2.1.10 10395
q Pantothenic acid, urinary pantothenate BD-1.13.9 10850 (specify) ___________________________________ P or F
excretion, plasma q Neurological CH-2.1.11 10396
q Biotin, urinary 3-hydroxyisovaleric acid BD-1.13.10 10851 (specify) ___________________________________ P or F
excretion or lymphocyte propionyl-CoA q Psychological CH-2.1.12 10397
carboxylase in pregnancy, serum (specify) ___________________________________ P or F
q Respiratory CH-2.1.13 10398
Nutrition-Focused Physical Findings (PD)
Montioring & Evaluation

(specify) ___________________________________ P or F
Findings from an evaluation of body systems, muscle and subcutaneous fat wasting, q Other CH-2.1.14 10399
oral health, suck/swallow/breathe ability, appetite, and affect. (specify) ___________________________________ P or F
Assessment &

Nutrition-focused physical findings (1.1) Treatments/therapy (2.2)

q Overall appearance PD-1.1.1 10362 Documented medical or surgical treatments that may impact nutritional status of the
(specify) ___________________________________ patient
q Body language PD-1.1.2 10363 q Medical treatment/therapy CH-2.2.1 10401
(specify) ___________________________________ (specify) ___________________________________
q Cardiovascular-pulmonary PD-1.1.3 10364 q Surgical treatment CH-2.2.2 10402
(specify) ___________________________________ (specify) ___________________________________
q Extremities, muscles and bones PD-1.1.4 10365 q Palliative/end-of-life care CH-2.2.3 10404
(specify) ___________________________________ (specify) ___________________________________
q Digestive system (mouth to rectum) PD-1.1.5 10366
(specify) ___________________________________ Social History (3)
q Head and eyes PD-1.1.6 10367 Patient/client socioeconomic status, housing situation, medical care support and
(specify) ___________________________________ involvement in social groups.
q Nerves and cognition PD-1.1.7 10368
Social history (3.1)
(specify) ___________________________________
q Socioeconomic factors CH-3.1.1 10407
q Skin PD-1.1.8 10369
(specify) ___________________________________
(specify) ___________________________________
q Living/housing situation CH-3.1.2 10408
q Vital signs PD-1.1.9 10370
(specify) ___________________________________
(specify) ___________________________________
q Domestic issues CH-3.1.3 10409
Client History (CH) (specify) ___________________________________
Current and past information related to personal, medical, family, and social history. q Social and medical support CH-3.1.4 10410
(specify) ___________________________________
Personal History (1) q Geographic location of home CH-3.1.5 10411
General patient/client information such as age, gender, race/ethnicity, language, (specify) ___________________________________
education, and role in family. q Occupation CH-3.1.6 10412
(specify) ___________________________________
Personal data (1.1)
q Religion CH-3.1.7 10413
q Age CH-1.1.1 10374
(specify) ___________________________________
q Gender CH-1.1.2 10375
q History of recent crisis CH-3.1.8 10414
q Race/Ethnicity CH-1.1.3 10376
(specify) ___________________________________
q Language CH-1.1.4 10377
q Daily stress level CH-3.1.9 10415
q Literacy factors CH-1.1.5 10378
q Education CH-1.1.6 10379 COMPARATIVE STANDARDS (CS)
q Role in family CH-1.1.7 10380
q Tobacco use CH-1.1.8 10381 Energy Needs (1)
q Physical disability CH-1.1.9 10382
Estimated energy needs (1.1)
q Mobility CH-1.1.10 10383
q Total energy estimated needs CS-1.1.1 10419
Patient/Client/Family Medical/Health History (2) q Method for estimating needs CS-1.1.2 10420
Patient/client or family disease states, conditions, and illnesses that may have
Macronutrient Needs (2)
nutritional impact.
Estimated fat needs (2.1)
Patient/client OR family nutrition-oriented medical/health history (2.1)
q Total fat estimated needs CS-2.1.1 10423
Specify issue(s) and whether it is patient/client history (P) or family history (F) q Type of fat needed CS-2.1.2 10424
q Patient/client chief nutrition complaint CH-2.1.1 10386 q Method for estimating needs CS-2.1.3 10425
(specify) __________________________________ P or F
q Cardiovascular CH-2.1.2 10387 Estimated protein needs (2.2)
(specify) ___________________________________ P or F q Total protein estimated needs CS-2.2.1 10427
q Endocrine/metabolism CH-2.1.3 10388 q Type of protein needed CS-2.2.2 10428
(specify) ___________________________________ P or F q Method for estimating needs CS-2.2.3 10429
q Excretory CH-2.1.4 10389
(specify) ___________________________________ P or F

4th Edition 418

 Nutrition Assessment and Monitoring and Evaluation Terminology, cont’d
Estimated carbohydrate needs (2.3) Estimated mineral needs (4.2)
q Total carbohydrate estimated needs CS-2.3.1 10431 q Calcium (1) 10460 q Copper (11) 10471
q Type of carbohydrate needed CS-2.3.2 10432 q Chloride (2) 10461 q Iodine (12) 10473
q Method for estimating needs CS-2.3.3 10433 q Iron (3) 10462 q Selenium (13) 10474
Estimated fiber needs (2.4) q Magnesium (4) 10463 q Manganese (14) 10475
q Total fiber estimated needs CS-2.4.1 10435 q Potassium (5) 10464 q Chromium (15) 10476
q Type of fiber needed CS-2.4.2 10436 q Phosphorus (6) 10465 q Molybdenum (16) 10477
q Method for estimating needs CS-2.4.3 10437 q Sodium (7) 10466 q Boron (17) 10478
q Zinc (8) 10467 q Cobalt (18) 10479
Fluid Needs (3) q Sulfate (9) 10469 q Method for estimating 10480
Estimated fluid needs (3.1) q Fluoride (10) 10470 needs (19)
q Total fluid estimated needs CS-3.1.1 10440
q Method for estimating needs CS-3.1.2 10441 Weight and Growth Recommendation (5)
Recommended body weight/body mass Index/growth (5.1)
Micronutrient Needs (4) q Ideal/reference body weight (IBW) CS-5.1.1 10483
Estimated vitamin needs (4.1) q Recommended body mass index (BMI) CS-5.1.2 10484
q A (1) 10444 q Niacin (8) 10451 q Desired growth pattern CS-5.1.3 10485
q C (2) 10445 q Folate (9) 10452
q D (3) 10446 q B6 (10) 10453

Montioring & Evaluation

q E (4) 10447 q B12 (11) 10454
q K (5) 10448 q Pantothenic acid (12) 10455
q Thiamin (6) 10449 q Biotin (13) 10456

Assessment &
q Riboflavin (7) 10450 q Method for estimating 10458
needs (14)

419 4th Edition

 Nutrition DiagnosticTerminology
Each term has an Academy unique identifier, a five-digit number (e.g., 99999) following the alpha-numeric IDNT code. Neither should be visible in
nutrition documentation. The Academy unique identifier is for data tracking purposes in electronic records.

INTAKE NI Vitamin (5.9)

Defined as “actual problems related to intake of energy, nutrients, fluids, bioactive q Inadequate vitamin intake (specify) NI-5.9.1
substances through oral diet or nutrition support” q A (1) 10679 q Niacin (8) 10686
q C (2) 10680 q Folate (9) 10687
Energy Balance (1) q D (3) 10681 q B6 (10) 10688
Defined as “actual or estimated changes in energy (calorie/kcal/kJ) balance” q E (4) 10682 q B12 (11) 10689
q Increased energy expenditure NI-1.1 10633 q K (5) 10683 q Pantothenic acid (12) 10690
q Inadequate energy intake NI-1.2 10634 q Thiamin (6) 10684 q Biotin (13) 10691
q Excessive energy intake NI-1.3 10635 q Riboflavin (7) 10685
q Predicted suboptimal energy intake NI-1.4 10636 q Excessive vitamin intake (specify) NI-5.9.2
q Predicted excessive energy intake NI-1.5 10637 q A (1) 10694 q Niacin (8) 10701
q C (2) 10695 q Folate (9) 10702
Oral or Nutrition Support Intake (2) q D (3) 10696 q B6 (10) 10703
Defined as “actual or estimated food and beverage intake from oral diet or nutrition q E (4) 10697 q B12 (11) 10704
support compared with patient goal” q K (5) 10698 q Pantothenic acid (12) 10705
q Inadequate oral intake NI-2.1 10639 q Thiamin (6) 10699 q Biotin (13) 10706
q Excessive oral intake NI-2.2 10640 q Riboflavin (7) 10700
q Inadequate enteral nutrition infusion NI-2.3 10641
q Excessive enteral nutrition infusion NI-2.4 10642 Mineral (5.10)
q Less than optimal enteral nutrition composition NI-2.5 10852 q Inadequate mineral intake (specify) NI-5.10.1
or modality q Calcium (1) 10710 q Fluoride (10) 10719
q Inadequate parenteral nutrition infusion NI-2.6 10644 q Chloride (2) 10711 q Copper (11) 10720
q Excessive parenteral nutrition infusion NI-2.7 10645 q Iron (3) 10712 q Iodine (12) 10721
q Less than optimal parenteral nutrition composition NI-2.8 10853 q Magnesium (4) 10713 q Selenium (13) 10722
or modality q Potassium (5) 10714 q Manganese (14) 10723
q Limited food acceptance NI-2.9 10647 q Phosphorus (6) 10715 q Chromium (15) 10724
q Sodium (7) 10716 q Molybdenum (16) 10725
Fluid Intake (3) q Zinc (8) 10717 q Boron (17) 10726
Defined as “actual or estimated fluid intake compared with patient goal” q Sulfate (9) 10718 q Cobalt (18) 10727
q Inadequate fluid intake NI-3.1 10649 q Excessive mineral intake (specify) NI-5.10.2
q Excessive fluid intake NI-3.2 10650 q Calcium (1) 10730 q Fluoride (10) 10739
q Chloride (2) 10731 q Copper (11) 10740
Bioactive Substances (4) q Iron (3) 10732 q Iodine (12) 10741
Defined as “actual or observed intake of bioactive substances, including single or q Magnesium (4) 10733 q Selenium (13) 10742
multiple functional food components, ingredients, dietary supplements, alcohol” q Potassium (5) 10734 q Manganese (14) 10743
q Suboptimal bioactive substance intake NI-4.1 10859 q Phosphorus (6) 10735 q Chromium (15) 10744
(specify)___________________________________ q Sodium (7) 10736 q Molybdenum (16) 10745
q Excessive bioactive substance intake NI-4.2 10653 q Zinc (8) 10737 q Boron (17) 10746
(specify)___________________________________ q Sulfate (9) 10738 q Cobalt (18) 10747
q Excessive alcohol intake NI-4.3 10654
Multi-nutrient (5.11)
Nutrient (5) q Predicted suboptimal nutrient intake NI-5.11.1 10750
Defined as “actual or estimated intake of specific nutrient groups or single nutrients (specify)___________________________________

Diagnosis
as compared with desired levels” q Predicted excessive nutrient intake NI-5.11.2 10751
q Increased nutrient needs NI-5.1 10656 (specify)___________________________________
(specify)___________________________________
CLINICAL NC
q Malnutrition NI-5.2 10657
Defined as “nutritional findings/problems identified that relate to medical or
q Inadequate protein-energy intake NI-5.3 10658
physical conditions”
q Decreased nutrient needs NI-5.4 10659
(specify)___________________________________ Functional (1)
q Imbalance of nutrients NI-5.5 10660 Defined as “change in physical or mechanical functioning that interferes with or
Fat and Cholesterol (5.6) prevents desired nutritional consequences”
q Inadequate fat intake NI-5.6.1 10662 q Swallowing difficulty NC-1.1 10754
q Excessive fat intake NI-5.6.2 10663 q Biting/Chewing (masticatory) difficulty NC-1.2 10755
q Less than optimal intake of types of fats NI-5.6.3 10854 q Breastfeeding difficulty NC-1.3 10756
(specify)___________________________________ q Altered GI function NC-1.4 10757
Protein (5.7) Biochemical (2)
q Inadequate protein intake NI-5.7.1 10666 Defined as “change in capacity to metabolize nutrients as a result of medications,
q Excessive protein intake NI-5.7.2 10667 surgery, or as indicated by altered lab values”
q Less than optimal intake of types of proteins or NI-5.7.3 10855 q Impaired nutrient utilization NC-2.1 10759
amino acids (specify)_________________________ q Altered nutrition-related laboratory values NC-2.2 10760
(specify) __________________________________
Carbohydrate and Fiber (5.8)
q Food–medication interaction NC-2.3 10761
q Inadequate carbohydrate intake NI-5.8.1 10670
(specify)___________________________________
q Excessive carbohydrate intake NI-5.8.2 10671 q Predicted food–medication interaction NC-2.4 10762
q Less than optimal intake of types NI-5.8.3 10856 (specify)___________________________________
of carbohydrate (specify)______________________
q Inconsistent carbohydrate intake NI-5.8.4 10673
q Inadequate fiber intake NI-5.8.5 10675
q Excessive fiber intake NI-5.8.6 10676

421 4th Edition

 Nutrition DiagnosticTerminology
Weight (3) Physical Activity and Function (2)
Defined as “chronic weight or changed weight status when compared with usual or Defined as “actual physical activity, self-care, and quality-of-life problems as
desired body weight” reported, observed, or documented”
q Underweight NC-3.1 10764 q Physical inactivity NB-2.1 10782
q Unintended weight loss NC-3.2 10765 q Excessive physical activity NB-2.2 10783
q Overweight/obesity NC-3.3 q Inability to manage self-care NB-2.3 10780
q Overweight, adult or pediatric (1) 10767 q Impaired ability to prepare foods/meals NB-2.4 10785
q Obese, pediatric (2) 10768 q Poor nutrition quality of life NB-2.5 10786
q Obese, Class I (3) 10769 q Self-feeding difficulty NB-2.6 10787
q Obese, Class II (4) 10818
q Obese, Class III (5) 10819 Food Safety and Access (3)
q Unintended weight gain NC-3.4 10770 Defined as “actual problems with food safety or access to food, water, or nutrition-
q Suboptimal growth rate NC-3.5 10802 related supplies”
q Excessive growth rate NC-3.6 10803 q Intake of unsafe food NB-3.1 10789
q Limited access to food or water NB-3.2 10790
BEHAVIORAL-ENVIRONMENTAL NB q Limited access to nutrition-related supplies NB-3.3 10791
Defined as “nutritional findings/problems identified that relate to knowledge,
attitudes/beliefs, physical environment, access to food, or food safety” other N0
Defined as “nutrition findings that are not classified as intake, clinical or
Knowledge and Beliefs (1) behavioral-environmental problems.”
Defined as “actual knowledge and beliefs as related, observed, or
documented” Other (1)
q Food- and nutrition-related knowledge deficit NB-1.1 10773 q No nutrition diagnosis at this time N0-1.1 10795
q Unsupported beliefs/attitudes about food- NB-1.2 10857
or nutrition-related topics (use with caution)
q Not ready for diet/lifestyle change NB-1.3 10775
q Self-monitoring deficit NB-1.4 10776
q Disordered eating pattern NB-1.5 10777
q Limited adherence to nutrition-related NB-1.6 10778
recommendations
q Undesirable food choices NB-1.7 10779
Diagnosis

4th Edition 422

 Nutrition Intervention Terminology
Each term has an Academy unique identifier, a five-digit number (e.g., 99999) following the alpha-numeric IDNT code. Neither should be visible in
nutrition documentation. The Academy unique identifier is for data tracking purposes in electronic records.

Nutrition Prescription NP-1.1 10794

The patient/client’s individualized recommended dietary intake of energy and/or selected foods or nutrients based on current reference standards and dietary
guidelines and the patient/client’s health condition and nutrition diagnosis (specify).

___________________________________________________________________________________________________________________
___________________________________________________________________________________________________________________
___________________________________________________________________________________________________________________

food and/or nutrient delivery ND Vitamin and Mineral Supplements (3.2)

Individualized approach for food /nutrient provision. Supplemental vitamins or minerals.
q Multivitamin/mineral ND-3.2.1 10521
Meals and Snacks (1) q Multi-trace elements ND-3.2.2 10522
Regular eating episode (meal); food served between regular meals (snack). q Vitamin ND-3.2.3
q General/healthful diet ND-1.1 10489 q A (1) 10524 qNiacin (8) 10531
q Composition of meals/snacks ND-1.2 q C (2) 10525 qFolate (9) 10532
q Texture-modified diet (1) 10829 q D (3) 10526 qB6 (10) 10533
q Energy-modified diet (2) 10830 q E (4) 10527 qB12 (11) 10534
q Protein-modified diet (3) 10831 q K (5) 10528 qPantothenic acid (12) 10535
q Carbohydrate-modified diet (4) 10832 q Thiamin (6) 10529 qBiotin (13) 10536
q Fat-modified diet (5) 10833 q Riboflavin (7) 10530
q Fiber-modified diet (6) 10834 q Mineral ND-3.2.4
q Fluid-modified diet (7) 10835 q Calcium (1) 10539 qFluoride (10) 10548
q Diets modified for specific 10836 q Chloride (2) 10540 qCopper (11) 10549
foods or ingredients (8) q Iron (3) 10541 qIodine (12) 10550
q Vitamin-modified diet (9) 10837 q Magnesium (4) 10542 qSelenium (13) 10551
q Mineral-modified diet (10) 10838 q Potassium (5) 10543 qManganese (14) 10552
q Schedule of food/fluids ND-1.3 10815 q Phosphorus (6) 10544 qChromium (15) 10553
q Specific foods/beverages or groups ND-1.4 10492 q Sodium (7) 10545 qMolybdenum (16) 10554
q Other ND-1.5 10493 q Zinc (8) 10546 qBoron (17) 10555
(specify) ___________________________________ q Sulfate (9) 10547 qCobalt (18) 10556

Enteral and Parenteral Nutrition (2) Bioactive Substance Management (3.3)

Nutrition provided through the GI tract via tube, catheter, or stoma (enteral) or Addition or change in provision of bioactive substances.
intravenously (centrally or peripherally) (parenteral). q Plant stanol esters ND-3.3.1 10559
q Plant sterol esters ND-3.3.2 10816
Enteral Nutrition (2.1) q Soy protein ND-3.3.3 10561
Nutrition provided through the GI tract. q Psyllium ND-3.3.4 10817
q Composition ND-2.1.1 10503 q b-glucan ND-3.3.5 10563
q Concentration ND-2.1.2 10502 q Food additives (specify) ND-3.3.6 10564
q Rate ND-2.1.3 10500 q Alcohol ND-3.3.7 10565
q Volume ND-2.1.4 10501 q Caffeine ND-3.3.8 10566
q Schedule ND-2.1.5 10504 q Other (specify) ND-3.3.9 10567
q Route ND-2.1.6 10792
q Insert enteral feeding tube ND-2.1.7 10497 Feeding Assistance (4)
q Site care ND-2.1.8 10498 Accommodation or assistance in eating.
q Feeding tube flush ND-2.1.9 10499 q Adaptive eating device ND-4.1 10808
Parenteral Nutrition/IV Fluids (2.2) q Feeding position ND-4.2 10570
Nutrition and fluids provided intravenously. q Meal set-up ND-4.3 10571
q Composition ND-2.2.1 10511 q Mouth care ND-4.4 10572
q Concentration ND-2.2.2 10510 q Menu selection assistance ND-4.5 10809
q Rate ND-2.2.3 10509 q Other ND-4.6 10573
q Schedule ND-2.2.4 10512 (specify) ___________________________________
q Route ND-2.2.5 10793
q Site care ND-2.2.6 10507
Feeding Environment (5)
Adjustment of the factors where food is served that impact food consumption.
q IV fluids ND-2.2.7 10508
q Lighting ND-5.1 10575
Supplements (3) q Odors ND-5.2 10576
q Distractions ND-5.3 10577
Medical Food Supplements (3.1)
q Table height ND-5.4 10578
Commercial or prepared foods or beverages that supplement energy, protein,
Intervention

q Table service ND-5.5 10849

carbohydrate, fiber, fat intake.
q Room temperature ND-5.6 10580
q Commercial beverage ND-3.1.1 10515
q Meal service ND-5.7 10810
q Commercial food ND-3.1.2 10516
q Meal location ND-5.8 10811
q Modified beverage ND-3.1.3 10517
q Other ND-5.9 10581
q Modified food ND-3.1.4 10518
(specify) ___________________________________
q Purpose ND-3.1.5 10519
(specify) ___________________________________

423 4th Edition

 Nutrition Intervention Terminology, cont’d
Nutrition-Related Medication Management (6) Strategies (2)
Modification of a medication or complementary/alternative medicine to optimize Selectively applied evidence-based methods or plans of action designed to achieve a
patient/client nutritional or health status. particular goal.
q Prescription medications ND-6.1 10839 q Motivational interviewing C-2.1 10607
q OTC medication ND-6.2 10584 q Goal setting C-2.2 10608
q Nutrition-related complementary/ ND-6.3 10799 q Self-monitoring C-2.3 10609
alternative medicine q Problem solving C-2.4 10610
q Social support C-2.5 10611
Nutrition Education E q Stress management C-2.6 10612
Formal process to instruct or train patients/clients in a skill or to impart knowledge q Stimulus control C-2.7 10613
to help patients/clients voluntarily manage or modify food, nutrition and physical q Cognitive restructuring C-2.8 10614
activity choices and behavior to maintain or improve health. q Relapse prevention C-2.9 10615
q Rewards/contingency management C-2.10 10616
Nutrition Education–Content (1)
q Other C-2.11 10617
Instruction or training intended to lead to nutrition-related knowledge.
(specify) ___________________________________
q Purpose of the nutrition education E-1.1 10588
q Priority modifications E-1.2 10589 coordination of nutrition care RC
q Survival information E-1.3 10590 Consultation with, referral to, or coordination of nutrition care with other providers,
q Nutrition relationship to health/disease E-1.4 10591 institutions, or agencies that can assist in treating or managing nutrition-related
q Recommended modifications E-1.5 10592 problems.
q Other or related topics E-1.6 10593
q Other E-1.7 10594 Collaboration and Referral of Nutrition Care (1)
(specify) ___________________________________ Facilitating services with other professionals, institutions, or agencies during
nutrition care.
Nutrition Education–Application (2) q Team meeting RC-1.1 10620
Instruction or training leading to nutrition-related result interpretation or q Referral to RD with different expertise RC-1.2 10621
skills. q Collaboration with other nutrition professionals RC-1.3 10622
q Result interpretation E-2.1 10596 q Collaboration with other providers RC-1.4 10623
q Skill development E-2.2 10597 q Referral to other providers RC-1.5 10624
q Other E-2.3 10598 q Referral to community agencies/programs RC-1.6 10625
(specify) _______________________________ (specify) __________________________________

Nutrition counseling C Discharge and Transfer of Nutrition Care to New Setting

A supportive process, characterized by a collaborative counselor–patient/client or Provider (2)
relationship to establish food, nutrition and physical activity priorities, goals, and Discharge planning and transfer of nutrition care from one level or location of care
individualized action plans that acknowledge and foster responsibility for self-care to another.
to treat an existing condition and promote health. q Discharge and transfer to other providers RC-2.1 10813
q Discharge and transfer to community RC-2.2 10814
Theoretical Basis/Approach (1)
agencies/programs
The theories or models used to design and implement an intervention.
q Discharge and transfer to another RC-2.3 10627
q Cognitive-Behavioral Theory C-1.1 10601
nutrition professional
q Health Belief Model C-1.2 10602
q Social Learning Theory C-1.3 10603
q Transtheoretical Model/ Stages of Change C-1.4 10604
q Other C-1.5 10605
(specify) ___________________________________
Intervention

4th Edition 424